Literature DB >> 23478086

Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.

David P Nichols1, Silvia Caceres, Lindsay Caverly, Cori Fratelli, Sun Ho Kim, Ken Malcolm, Katie R Poch, Milene Saavedra, George Solomon, Jennifer Taylor-Cousar, Samuel Moskowitz, Jerry A Nick.   

Abstract

BACKGROUND: Cutaneous thermal injuries (i.e., burns) remain a common form of debilitating trauma, and outcomes are often worsened by wound infection with environmental bacteria, chiefly Pseudomonas aeruginosa.
MATERIALS AND METHODS: We tested the effects of early administration of a single dose of azithromycin, with or without subsequent antipseudomonal antibiotics, in a mouse model of standardized thermal injury infected with P aeruginosa via both wound site and systemic infection. We also tested the antimicrobial effects of these antibiotics alone or combined in comparative biofilm and planktonic cultures in vitro.
RESULTS: In our model, early azithromycin administration significantly reduced wound and systemic infection without altering wound site or circulating neutrophil activity. The antimicrobial effect of azithromycin was additive with ciprofloxacin but significantly reduced the antimicrobial effect of tobramycin. This pattern was reproduced in biofilm cultures and not observed in planktonic cultures of P aeruginosa.
CONCLUSION: These data suggest that early administration of azithromycin following burn-related trauma and infection may reduce P aeruginosa infection and potential interactions with other antibiotics should be considered when designing future studies.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Azithromycin; Biofilm; Burn; Burn wound; Ciprofloxacin; Cystic fibrosis; Drug–drug interaction; Pseudomonas aeruginosa; Thermal injury; Tobramycin

Mesh:

Substances:

Year:  2013        PMID: 23478086      PMCID: PMC3713079          DOI: 10.1016/j.jss.2013.02.003

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  39 in total

Review 1.  Molecular tools for study of biofilm physiology.

Authors:  B B Christensen; C Sternberg; J B Andersen; R J Palmer; A T Nielsen; M Givskov; S Molin
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Experimental reproducibility in flow-chamber biofilms.

Authors:  A Heydorn; B K Ersbøll; M Hentzer; M R Parsek; M Givskov; S Molin
Journal:  Microbiology       Date:  2000-10       Impact factor: 2.777

3.  Quantification of biofilm structures by the novel computer program COMSTAT.

Authors:  A Heydorn; A T Nielsen; M Hentzer; C Sternberg; M Givskov; B K Ersbøll; S Molin
Journal:  Microbiology       Date:  2000-10       Impact factor: 2.777

Review 4.  An overview of war-related thermal injuries.

Authors:  Rosiane Alfinito Roeder; Carl I Schulman
Journal:  J Craniofac Surg       Date:  2010-07       Impact factor: 1.046

5.  Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial.

Authors:  P Robinson; Michael S Schechter; Peter D Sly; Kaye Winfield; Julie Smith; Siobhain Brennan; Masaharu Shinkai; Markus O Henke; Bruce K Rubin
Journal:  Pediatr Pulmonol       Date:  2012-01-20

6.  Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model.

Authors:  Marie Tré-Hardy; Carole Nagant; Naïma El Manssouri; Francis Vanderbist; Hamidou Traore; Mario Vaneechoutte; Jean-Paul Dehaye
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

7.  Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.

Authors:  Miriam M Treggiari; George Retsch-Bogart; Nicole Mayer-Hamblett; Umer Khan; Michal Kulich; Richard Kronmal; Judy Williams; Peter Hiatt; Ronald L Gibson; Terry Spencer; David Orenstein; Barbara A Chatfield; Deborah K Froh; Jane L Burns; Margaret Rosenfeld; Bonnie W Ramsey
Journal:  Arch Pediatr Adolesc Med       Date:  2011-09

8.  Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects.

Authors:  Ognjen Culić; Vesna Eraković; Ivana Cepelak; Karmela Barisić; Karmen Brajsa; Zeljko Ferencić; Ruzica Galović; Ines Glojnarić; Zoran Manojlović; Vesna Munić; Renata Novak-Mircetić; Verica Pavicić-Beljak; Mirna Sucić; Marija Veljaca; Tihana Zanić-Grubisić; Michael J Parnham
Journal:  Eur J Pharmacol       Date:  2002-08-30       Impact factor: 4.432

9.  Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.

Authors:  S T O'Sullivan; J A Lederer; A F Horgan; D H Chin; J A Mannick; M L Rodrick
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

10.  Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety, and mechanism of action.

Authors:  Tianhong Dai; Asheesh Gupta; Ying-Ying Huang; Rui Yin; Clinton K Murray; Mark S Vrahas; Margaret E Sherwood; George P Tegos; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2012-12-21       Impact factor: 5.191

View more
  16 in total

1.  Pseudomonas aeruginosa elastase disrupts the cortisol-binding activity of corticosteroid-binding globulin.

Authors:  Marc Simard; Lesley A Hill; Caroline M Underhill; Bernd O Keller; Ivan Villanueva; Robert E W Hancock; Geoffrey L Hammond
Journal:  Endocrinology       Date:  2014-05-21       Impact factor: 4.736

2.  Recombinant outer membrane protein F-B subunit of LT protein as a prophylactic measure against Pseudomonas aeruginosa burn infection in mice.

Authors:  Hassan Heydari Farsani; Iraj Rasooli; Seyed Latif Mousavi Gargari; Shahram Nazarian; Shakiba Darwish Alipour Astaneh
Journal:  World J Methodol       Date:  2015-12-26

3.  Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products.

Authors:  Silvia M Caceres; Kenneth C Malcolm; Jennifer L Taylor-Cousar; David P Nichols; Milene T Saavedra; Donna L Bratton; Samuel M Moskowitz; Jane L Burns; Jerry A Nick
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

4.  Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis.

Authors:  Dave P Nichols; Carrie L Happoldt; Preston E Bratcher; Silvia M Caceres; James F Chmiel; Kenneth C Malcolm; Milene T Saavedra; Lisa Saiman; Jennifer L Taylor-Cousar; Jerry A Nick
Journal:  J Cyst Fibros       Date:  2016-12-24       Impact factor: 5.482

5.  Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis.

Authors:  Ranjani Somayaji; Renee Russell; Jonathan D Cogen; Cristopher H Goss; Sarah E Nick; Milene T Saavedra; Jennifer L Taylor-Cousar; Jerry A Nick; Dave P Nichols
Journal:  Ann Am Thorac Soc       Date:  2019-07

6.  Effects of Fluoroquinolones and Azithromycin on Biofilm Formation of Stenotrophomonas maltophilia.

Authors:  Aihua Wang; Qinqin Wang; Timothy Kudinha; Shunian Xiao; Chao Zhuo
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

7.  Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.

Authors:  Jonathan D Cogen; Anna V Faino; Frankline Onchiri; Ronald L Gibson; Lucas R Hoffman; Matthew P Kronman; Margaret Rosenfeld; David P Nichols
Journal:  Ann Am Thorac Soc       Date:  2021-02

8.  Azithromycin may antagonize inhaled tobramycin when targeting Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Jerry A Nick; Samuel M Moskowitz; James F Chmiel; Anna V Forssén; Sun Ho Kim; Milene T Saavedra; Lisa Saiman; Jennifer L Taylor-Cousar; David P Nichols
Journal:  Ann Am Thorac Soc       Date:  2014-03

9.  Selection of Single-Stranded DNA Molecular Recognition Elements against Exotoxin A Using a Novel Decoy-SELEX Method and Sensitive Detection of Exotoxin A in Human Serum.

Authors:  Ka Lok Hong; Kailey Yancey; Luisa Battistella; Ryan M Williams; Katherine M Hickey; Chris D Bostick; Peter M Gannett; Letha J Sooter
Journal:  Biomed Res Int       Date:  2015-11-09       Impact factor: 3.411

10.  Fabrication of a Selective and Sensitive Sensor Based on Molecularly Imprinted Polymer/Acetylene Black for the Determination of Azithromycin in Pharmaceuticals and Biological Samples.

Authors:  Tingting Zhou; Yun Tao; Hua Jin; Bin Song; Tao Jing; Dan Luo; Yusun Zhou; Yikai Zhou; Yong-Ill Lee; Surong Mei
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.